Type 2 diabetes and/or its treatment leads to less cognitive impairment in Alzheimer's disease patients

Abstract Aim To evaluate the cognitive performance of a homogeneous population of Alzheimer's disease (AD), non-demented Type 2 Diabetes Mellitus (DIAB), demented with concomitant diseases (AD+DIAB) and healthy control subjects. AD is a progressive dementia disorder characterized clinically by...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes research and clinical practice 2012-10, Vol.98 (1), p.68-74
Hauptverfasser:	Domínguez, Raúl O, Marschoff, Enrique R, González, Silvia E, Repetto, Marisa G, Serra, Jorge A
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Alzheimer Disease - blood Alzheimer Disease - physiopathology Alzheimer's disease Argentina Cognition Disorders - blood Cognition Disorders - physiopathology Cognitive performance Cognitive tests Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - drug therapy Diabetes Mellitus, Type 2 - physiopathology Disease Progression Endocrinology & Metabolism Female Geriatric Assessment Hippocampus - drug effects Hippocampus - physiopathology Humans Hypoglycemic Agents - pharmacology Insulin - metabolism Longitudinal Studies Male Neuropsychological Tests Oxidative Stress Pilot Projects Psychiatric Status Rating Scales Severity of Illness Index Thiazolidinediones - pharmacology Type 2 Diabetes Mellitus
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!